Inflammation and immune dysfunction in Parkinson disease

MG Tansey, RL Wallings, MC Houser… - Nature Reviews …, 2022 - nature.com
Parkinson disease (PD) is a progressive neurodegenerative disease that affects peripheral
organs as well as the central nervous system and involves a fundamental role of …

MR biomarkers of degenerative brain disorders derived from diffusion imaging

C Andica, K Kamagata, T Hatano… - Journal of Magnetic …, 2020 - Wiley Online Library
The incidence of neurodegenerative diseases has shown an increasing trend. These
conditions typically cause progressive functional disability. Identification of robust …

Neurite orientation dispersion and density imaging (NODDI) and free‐water imaging in Parkinsonism

T Mitchell, DB Archer, WT Chu… - Human Brain …, 2019 - Wiley Online Library
Neurite orientation dispersion and density imaging (NODDI) uses a three‐compartment
model to probe brain tissue microstructure, whereas free‐water (FW) imaging models two …

Diffusion magnetic resonance imaging-based biomarkers for neurodegenerative diseases

K Kamagata, C Andica, A Kato, Y Saito… - International Journal of …, 2021 - mdpi.com
There has been an increasing prevalence of neurodegenerative diseases with the rapid
increase in aging societies worldwide. Biomarkers that can be used to detect pathological …

Diffusion tensor imaging in Parkinson's disease and parkinsonian syndrome: a systematic review

Y Zhang, MA Burock - Frontiers in neurology, 2020 - frontiersin.org
Diffusion tensor imaging (DTI) allows measuring fractional anisotropy and similar
microstructural indices of the brain white matter. Lower than normal fractional anisotropy as …

MRI biomarkers of motor and non-motor symptoms in Parkinson's disease

SG Ryman, KL Poston - Parkinsonism & related disorders, 2020 - Elsevier
Parkinson's disease is a heterogeneous disorder with both motor and non-motor symptoms
that contribute to functional impairment. To develop effective, disease modifying treatments …

Neuroinflammation and mitochondrial dysfunction in parkinson's disease: connecting neuroimaging with pathophysiology

BM Pizarro-Galleguillos, L Kunert, N Brüggemann… - Antioxidants, 2023 - mdpi.com
There is a pressing need for disease-modifying therapies in patients suffering from
neurodegenerative diseases, including Parkinson's disease (PD). However, these disorders …

Tremor pathophysiology: lessons from neuroimaging

AMM van der Stouwe, F Nieuwhof… - Current opinion in …, 2020 - journals.lww.com
The pathophysiology of all investigated tremors involves the cerebello-thalamo-cortical
pathway, and clinical and pathophysiological features overlap among tremor disorders. We …

Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa‐Induced Dyskinesia

D Su, Y Gan, Z Zhang, Y Cui, Z Zhang, Z Liu… - Movement …, 2023 - Wiley Online Library
Background Degeneration of the substantia nigra (SN) may contribute to levodopa‐induced
dyskinesia (LID) in Parkinson's disease (PD), but the exact characteristics of SN in LID …

Molecular Imaging in Parkinsonian Disorders—What's New and Hot?

S Prange, H Theis, M Banwinkler, T van Eimeren - Brain Sciences, 2022 - mdpi.com
Highlights Imaging of the dopamine transporter (DAT)(in particular using 11C-or 18F-PE2I)
most reliably and precisely measures neurodegeneration of the dopaminergic system in …